Search In this Thesis
   Search In this Thesis  
العنوان
New updates in Uses Of
Extra Corporeal Membrane Oxygenation/
المؤلف
Shaaban,Ahmed Abdel kareem
هيئة الاعداد
باحث / أحمد عبد الكريم متولى شعبان
مشرف / جيهان فؤاد كامل
مشرف / وليد عبد المجيد محمد الطاهر
مشرف / رفيق يوسف عطا الله
تاريخ النشر
2017
عدد الصفحات
170.p:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
التخدير و علاج الألم
تاريخ الإجازة
1/1/2017
مكان الإجازة
جامعة عين شمس - كلية الطب - Critical Care Medicine
الفهرس
Only 14 pages are availabe for public view

from 170

from 170

Abstract

Abstract: Extracorporeal membrane oxygenation (ECMO) is a lifesaving therapy for patients with refractory severe respiratory failure or cardiac failure. Extracorporeal life support (ECLS) is a therapeutic option increasingly used in the management of patients with cardio-respiratory failure that is refractory to maximal conventional treatment. Developed as an offshoot of cardiopulmonary bypass and the membrane oxygenator, ECMO can be used in patients of all ages (newborn to adult). This support may facilitate therapeutic intervention, bridge to recovery, bridge to a long-term support device, heart or lung transplantation, or bridge to palliation.
Conclusion: The most common indications for veno-venous and veno-arterial ECMO remain severe hypoxemic respiratory failure and cardiogenic shock, respectively. Refinements in extracorporeal circuitry and cannulation strategies have led to novel indications for ECMO in cardiopulmonary failure, including pulmonary hypertension, extracorporeal cardiopulmonary resuscitation, and less severe forms of the acute respiratory distress syndrome.
References:
Abrams D and Brodie D. (2015) - Novel Uses of Extracorporeal Membrane Oxygenation in Adults. Clin Chest Med.; 36(3):373-84
S.R.Hosmane, T.Barrow and A.Ashworth (2015) -Extracorporeal membrane oxygenation: a radiologists’ guide to who, what and where Clinical Radiology 70e58e66.
M. Schmidt, A. Burrell and D. Pilcher (2015) - “Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score,” European Heart Journal 36(33):2246–2256